A look at how Boston Scientific has shaped the emerging med tech landscape, and where the ex-BSC-ers are making their impact now.

What’s the top life sciences market in the country? It’s Boston, according to a new study.In what’s sure to spark debate and friendly competition among the nation’s life science hubs, real estate and financial services firm Jones Lang LaSalle (NYSE:JLL) unveiled a report ranking the top life sciences clusters. Following Boston were New York/New Jersey, [...]

Temple University Hospital in Philadelphia is opening a Joslin Diabetes clinic in a partnership agreement with the Boston-based treatment center.It will be led by H. Howard Goldstein, MD, a diabetes specialist who comes to Temple from the Robert Wood Johnson Diabetes & Endocrinology Group in Hamilton, New Jersey.Temple’s diabetes center is the latest addition to [...]

NMT Medical Inc. (PINK:NMTI) began liquidating its assets in an attempt to repay its creditors.Officials at the Boston, Mass.-based company said it entered into an Assignment for the Benefit of Creditors, effective immediately. The legal maneuver is an alternative to formal bankruptcy that transfers all of NMT’s assets to a designated party, [...]

For its 9th birthday, the North Carolina biotech Entegrion is giving itself a present: a product on the market.The Research Triangle Park company has struck a licensing deal with a Boston-based medical device company to manufacture and market Entegrion’s Stasilon bandage: a proprietary weave of glass and bamboo fibers that promotes clotting. Chief Technology Officer [...]

These are hard times at NMT Medical Inc. (Public, PINK:NMTI), where officials said the company doesn’t have enough money to pay for its annual earnings filing with the federal Securities & Exchange Commission.Company officials said in Sept. 2010 that its existing cash resources were “not sufficient to fund our business plans, [...]

Monica Byrne’s science background is now the foundation of her fictional endeavors. The Durham, North Carolina woman who once aspired to become an astronaut is now a playwright and novelist.

Boston Scientific Corp.’s (NYSE:BSX) third-generation stent platform, the platinum-chromium Omega bare-metal stent, won CE Mark approval in the European Union. Boston Scientific said it plans to make the device available “immediately” in the EU and other countries that recognize the mark. It’s the first of a trio of stents the Natick, Mass.-based medical device maker plans to launch on the platform, according to a press release.

Boston Scientific layoffs will come from its cardiology, rhythm and vascular unit. Executives at BSX told employees that the cuts were coming so the medical company in Massachusetts could remain competitive.

Boston Scientific Corp.’s stock jumps as much as 6 percent after RBC Capital Markets boosts its rating of the medical device maker’s stock.